Role of prostate artery embolization in the management of refractory haematuria of prostatic origin

Keith Pereira, Joshua A. Halpern, Timothy D. McClure, Nicholas A. Lewis, Mohamed Kably, Shivank Bhatia, Jim C. Hu

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Prostatic haematuria is among the most common genitourinary complaints of emergency room visits, distressing and troublesome to men and a challenging clinical problem to the treating physician. The most common aetiologies of prostatic haematuria include benign prostatic hyperplasia and prostate cancer. Prostatic haematuria usually resolves with conservative and medical methods; failure of these interventions results in refractory haematuria of prostatic origin (RHPO), a potentially life-threatening scenario. Several different treatments have been described, with varying degrees of success. Patients with RHPO are often elderly and unfit for radical surgery. Prostate artery embolization (PAE) has evolved as a safe and effective technique in the management of RHPO. Use of a superselective approach optimizes clinical success while minimizing complications. This minimally invasive approach improves patients with haemodynamic instability, serves as a bridge to elective surgery, and is a highly effective treatment for RHPO. It may obviate the need for more invasive and morbid surgical therapies. The aim of the present review was to describe the current management of RHPO and the technique of PAE and to review its efficacy and associated morbidity.

Original languageEnglish (US)
Pages (from-to)359-365
Number of pages7
JournalBJU International
Volume118
Issue number3
DOIs
StatePublished - Sep 1 2016

Fingerprint

Hematuria
Prostate
Arteries
Prostatic Neoplasms
Prostatic Hyperplasia
Hospital Emergency Service
Therapeutics
Hemodynamics
Morbidity
Physicians

Keywords

  • benign prostatic hyperplasia
  • prostate artery embolization
  • prostate cancer
  • refractory haematuria

ASJC Scopus subject areas

  • Medicine(all)
  • Urology

Cite this

Pereira, K., Halpern, J. A., McClure, T. D., Lewis, N. A., Kably, M., Bhatia, S., & Hu, J. C. (2016). Role of prostate artery embolization in the management of refractory haematuria of prostatic origin. BJU International, 118(3), 359-365. https://doi.org/10.1111/bju.13524

Role of prostate artery embolization in the management of refractory haematuria of prostatic origin. / Pereira, Keith; Halpern, Joshua A.; McClure, Timothy D.; Lewis, Nicholas A.; Kably, Mohamed; Bhatia, Shivank; Hu, Jim C.

In: BJU International, Vol. 118, No. 3, 01.09.2016, p. 359-365.

Research output: Contribution to journalReview article

Pereira, K, Halpern, JA, McClure, TD, Lewis, NA, Kably, M, Bhatia, S & Hu, JC 2016, 'Role of prostate artery embolization in the management of refractory haematuria of prostatic origin', BJU International, vol. 118, no. 3, pp. 359-365. https://doi.org/10.1111/bju.13524
Pereira, Keith ; Halpern, Joshua A. ; McClure, Timothy D. ; Lewis, Nicholas A. ; Kably, Mohamed ; Bhatia, Shivank ; Hu, Jim C. / Role of prostate artery embolization in the management of refractory haematuria of prostatic origin. In: BJU International. 2016 ; Vol. 118, No. 3. pp. 359-365.
@article{745da89ae9b54570bb9e4f0f15216bfd,
title = "Role of prostate artery embolization in the management of refractory haematuria of prostatic origin",
abstract = "Prostatic haematuria is among the most common genitourinary complaints of emergency room visits, distressing and troublesome to men and a challenging clinical problem to the treating physician. The most common aetiologies of prostatic haematuria include benign prostatic hyperplasia and prostate cancer. Prostatic haematuria usually resolves with conservative and medical methods; failure of these interventions results in refractory haematuria of prostatic origin (RHPO), a potentially life-threatening scenario. Several different treatments have been described, with varying degrees of success. Patients with RHPO are often elderly and unfit for radical surgery. Prostate artery embolization (PAE) has evolved as a safe and effective technique in the management of RHPO. Use of a superselective approach optimizes clinical success while minimizing complications. This minimally invasive approach improves patients with haemodynamic instability, serves as a bridge to elective surgery, and is a highly effective treatment for RHPO. It may obviate the need for more invasive and morbid surgical therapies. The aim of the present review was to describe the current management of RHPO and the technique of PAE and to review its efficacy and associated morbidity.",
keywords = "benign prostatic hyperplasia, prostate artery embolization, prostate cancer, refractory haematuria",
author = "Keith Pereira and Halpern, {Joshua A.} and McClure, {Timothy D.} and Lewis, {Nicholas A.} and Mohamed Kably and Shivank Bhatia and Hu, {Jim C.}",
year = "2016",
month = "9",
day = "1",
doi = "10.1111/bju.13524",
language = "English (US)",
volume = "118",
pages = "359--365",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Role of prostate artery embolization in the management of refractory haematuria of prostatic origin

AU - Pereira, Keith

AU - Halpern, Joshua A.

AU - McClure, Timothy D.

AU - Lewis, Nicholas A.

AU - Kably, Mohamed

AU - Bhatia, Shivank

AU - Hu, Jim C.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Prostatic haematuria is among the most common genitourinary complaints of emergency room visits, distressing and troublesome to men and a challenging clinical problem to the treating physician. The most common aetiologies of prostatic haematuria include benign prostatic hyperplasia and prostate cancer. Prostatic haematuria usually resolves with conservative and medical methods; failure of these interventions results in refractory haematuria of prostatic origin (RHPO), a potentially life-threatening scenario. Several different treatments have been described, with varying degrees of success. Patients with RHPO are often elderly and unfit for radical surgery. Prostate artery embolization (PAE) has evolved as a safe and effective technique in the management of RHPO. Use of a superselective approach optimizes clinical success while minimizing complications. This minimally invasive approach improves patients with haemodynamic instability, serves as a bridge to elective surgery, and is a highly effective treatment for RHPO. It may obviate the need for more invasive and morbid surgical therapies. The aim of the present review was to describe the current management of RHPO and the technique of PAE and to review its efficacy and associated morbidity.

AB - Prostatic haematuria is among the most common genitourinary complaints of emergency room visits, distressing and troublesome to men and a challenging clinical problem to the treating physician. The most common aetiologies of prostatic haematuria include benign prostatic hyperplasia and prostate cancer. Prostatic haematuria usually resolves with conservative and medical methods; failure of these interventions results in refractory haematuria of prostatic origin (RHPO), a potentially life-threatening scenario. Several different treatments have been described, with varying degrees of success. Patients with RHPO are often elderly and unfit for radical surgery. Prostate artery embolization (PAE) has evolved as a safe and effective technique in the management of RHPO. Use of a superselective approach optimizes clinical success while minimizing complications. This minimally invasive approach improves patients with haemodynamic instability, serves as a bridge to elective surgery, and is a highly effective treatment for RHPO. It may obviate the need for more invasive and morbid surgical therapies. The aim of the present review was to describe the current management of RHPO and the technique of PAE and to review its efficacy and associated morbidity.

KW - benign prostatic hyperplasia

KW - prostate artery embolization

KW - prostate cancer

KW - refractory haematuria

UR - http://www.scopus.com/inward/record.url?scp=84982150770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84982150770&partnerID=8YFLogxK

U2 - 10.1111/bju.13524

DO - 10.1111/bju.13524

M3 - Review article

C2 - 27153766

AN - SCOPUS:84982150770

VL - 118

SP - 359

EP - 365

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - 3

ER -